User profiles for Majid Marjani

Majid Marjani

CTERC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Verified email at sbmu.ac.ir
Cited by 3921

[HTML][HTML] Diabetes mellitus and tuberculosis facts and controversies

P Baghaei, M Marjani, P Javanmard, P Tabarsi… - Journal of Diabetes & …, 2013 - Springer
Tuberculosis (TB) and diabetes mellitus (DM) are both important health issues. A bidirectional
association between them has been demonstrated by many researchers. The link of DM …

No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial

…, M Malekmohammad, P Tabarsi, M Marjani… - European Journal of …, 2021 - Elsevier
The aim of this study was to evaluate the clinical effects of dexamethasone administration in
patients with mild to moderate acute respiratory distress syndrome (ARDS) due to …

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

…, S Barati, H Jamaati, S Haseli, M Marjani… - International …, 2021 - Elsevier
Background The newly discovered coronavirus has turned into coronavirus disease 2019 (COVID-19)
pandemic and it rages at an unprecedented rate. Considering the findings of …

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial

F Dastan, SA Nadji, A Saffaei, M Marjani… - International …, 2020 - Elsevier
Background Recently, a new coronavirus spreads rapidly throughout the countries and resulted
in a worldwide epidemic. Interferons have direct antiviral and immunomodulatory effects. …

[HTML][HTML] First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance

M Shamaei, M Marjani, E Chitsaz, M Kazempour… - International Journal of …, 2009 - Elsevier
OBJECTIVE: Resistance to anti-tuberculosis (anti-TB) drugs is becoming a major and
alarming threat in most regions worldwide. METHODS: This was a descriptive cross-sectional …

[HTML][HTML] Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

…, N Shafigh, G Afzal, H Jamaati, P Tabarsi, M Marjani… - Pulmonology, 2021 - Elsevier
Background In December 2019, pneumonia associated with a novel coronavirus (COVID-19)
was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is the most …

Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial

F Dastan, A Saffaei, S Haseli, M Marjani… - International …, 2020 - Elsevier
Background The clinical presentation of SARS-CoV-2 infection ranges from mild symptoms
to severe complications, including acute respiratory distress syndrome. In this syndrome, …

[HTML][HTML] Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm

S Mahmoudi, M Rezaei, N Mansouri, M Marjani… - Journal of clinical …, 2020 - Springer
To the Editor: Since the emergence of Coronavirus Disease 2019 (COVID-19) caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …

[HTML][HTML] Increased serum levels of soluble TNF-α receptor is associated with ICU mortality in COVID-19 patients

…, SMR Hashemian, A Moniri, M Marjani… - Frontiers in …, 2021 - frontiersin.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes
coronavirus disease 2019 (COVID-19) has infected over 112M patients and resulted in almost …

Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients

…, M Rezaei, E Askari, B Farzanegan, M Marjani… - … -Research and Practice, 2020 - Elsevier
Background Since the outbreak of the novel coronavirus disease-2019 (COVID-19) in December
2019, limited studies have investigated the histopathologic findings of patients infected …